Fetal bovine serum Market Insights By Size, Share, Future Growth And Forecast From 2020-2030
The Fetal Bovine Serum Market - Global Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, production and consumption, supply chain analysis, competitive landscape, and market composition analysis.
Fetal bovine serum is extracted from clotted blood from fetal calves that are depleted of cells, fibrin and clotting factors and contain a large number of nutritional and macromolecular factors essential for cell growth. The major component of the fetal bovine serum is the bovine serum albumin. The fetal bovine serum is essential for the growth and maintenance of cultured cells. Consequently, the demand for fetal bovine serum is escalating for cell culture and biopharmaceutical manufacturing. Additionally, increasing focus on development of synthetic fetal bovine serum is anticipated to fuel the growth during the forecast period. The fetal bovine serum market is anticipated to expand at a CAGR of 5.0% during next decade.
Click Here to Download Sample Report @ https://www.insightslice.com/request-sample/297
Rising demand from human & animal vaccine production to generate demand for fetal bovine serum
The global fetal bovine serum market is segmented on the basis of product, application, end user, and geography. Based on application, the global fetal bovine serum market is segmented into drug discovery, cell culture media, in vitro fertilization, human & animal vaccine production, diagnostics, and others. The cell culture media applications of fetal bovine serum contributed largest share to the global market and is anticipated to grow at a prominent rate during forecast period as fetal bovine serum forms a prime supplement in development of cell culture media. It supplies growth nutrient for optimal development of cell culture media and thus, is widely used by biopharmaceutical manufacturers across the globe.
Rising investment in development of biopharmaceuticals to fuel demand for fetal bovine serum
Based on end user, the global fetal serum market is segmented into biotechnology & pharmaceutical manufacturers, academic institutes, and research Laboratory. Biotechnology & Pharmaceutical manufacturers dominated the global consumption of fetal bovine serum market and is anticipated to witness rampant growth during the forecast period. However, rising concern over the process involved in the manufacturing of fetal bovine serum is anticipated to impede market growth in coming years. Consequence have encouraged investment in research and development of synthetic bovine serum during the forecast period.
Based on geography, the market is segmented into North America, South America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the market in 2018 owing to focused developing and manufacturing of biopharmaceuticals and rise in aid from government in developing fetal bovine serum. South America is anticipated to contribute a prominent share to the market owing to rising demand for South America sourced fetal bovine serum across the globe. Fetal bovine serum market in Asia Pacific is anticipated to propel during the forecast period owing to rising demand from biopharmaceutical manufacturers.
Major players dominating the global fetal bovine serum market include Atlas Biologicals, Biological Industries, Biomol GmbH and Nucleus Biologics, Bio-Techne, Biowest, Caisson Laboratories, Inc., Cell Culture Technologies LLC, GE Healthcare, HiMedia Laboratories Pvt., Ltd., Merck KGaA (Sigma Aldrich), PAN-Biotech, Rocky Mountain Biologicals, Takara Bio, Inc., Thermo Fisher Scientific Inc. and Tissue Culture Biologicals.
Request For The Sample Report Here - https://www.insightslice.com/request-sample/297
insightSLICE is a market intelligenceand strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting with an aim to provide end-to-end solutions. For more details please contact our research and consulting team at [email protected].